Liver injury with novel oral anticoagulants: assessing post-marketing reports in the US Food and Drug Administration adverse event reporting system

AIM: We assessed the hepatic safety of novel oral anticoagulants (NOACs) analyzing the publicly available US-FDA adverse event reporting system (FAERS). METHODS: We extracted reports of drug-induced liver injury (DILI) associated with NOACs, including acute liver failure (ALF) events. Based on US ma...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Br J Clin Pharmacol
Main Authors: Raschi, Emanuel, Poluzzi, Elisabetta, Koci, Ariola, Salvo, Francesco, Pariente, Antoine, Biselli, Maurizio, Moretti, Ugo, Moore, Nicholas, De Ponti, Fabrizio
Formato: Artigo
Idioma:Inglês
Publicado em: John Wiley & Sons, Ltd 2015
Assuntos:
Drug Safety
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC4541976/
https://ncbi.nlm.nih.gov/pubmed/25689417
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/bcp.12611
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados